210 related articles for article (PubMed ID: 1576659)
1. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Burek CL; Hu Q; Kuppers RC; Lee B; Prendergast RA
Cell Immunol; 1992 May; 141(2):496-507. PubMed ID: 1576659
[TBL] [Abstract][Full Text] [Related]
2. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
Jabs DA; Kuppers RC; Saboori AM; Burek CL; Enger C; Lee B; Prendergast RA
Cell Immunol; 1994 Mar; 154(1):66-76. PubMed ID: 7907009
[TBL] [Abstract][Full Text] [Related]
3. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Burns WH; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
[TBL] [Abstract][Full Text] [Related]
4. Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Prendergast RA
Curr Eye Res; 1997 Sep; 16(9):909-16. PubMed ID: 9288452
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of non-depleting anti-CD4 in MRL/Mp-lpr/lpr mice with active systemic lupus erythematosus and microscopic angiitis.
Harper JM; Cook A
Autoimmunity; 2001; 33(4):245-51. PubMed ID: 11683399
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody.
Jabs DA; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2718-22. PubMed ID: 1680111
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice.
Merino R; Fossati L; Iwamoto M; Takahashi S; Lemoine R; Ibnou-Zekri N; Pugliatti L; Merino J; Izui S
J Autoimmun; 1995 Feb; 8(1):33-45. PubMed ID: 7734035
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
Giese T; Davidson WF
J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
[TBL] [Abstract][Full Text] [Related]
11. Evidence for major alterations in the thymocyte subpopulations in murine models of autoimmune diseases.
Kakkanaiah VN; Pyle RH; Nagarkatti M; Nagarkatti PS
J Autoimmun; 1990 Jun; 3(3):271-88. PubMed ID: 1975741
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties.
Kakkanaiah VN; Nagarkatti M; Nagarkatti PS
Cell Immunol; 1990 May; 127(2):442-57. PubMed ID: 2139366
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
[TBL] [Abstract][Full Text] [Related]
14. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.
Mountz JD; Zhou T; Eldridge J; Berry K; Blüthmann H
J Exp Med; 1990 Dec; 172(6):1805-17. PubMed ID: 1701823
[TBL] [Abstract][Full Text] [Related]
15. Ocular inflammation in MRL/Mp-lpr/lpr mice.
Jabs DA; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1944-7. PubMed ID: 2032814
[TBL] [Abstract][Full Text] [Related]
16. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
[TBL] [Abstract][Full Text] [Related]
17. Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice.
Ohteki T; Seki S; Abo T; Kumagai K
J Exp Med; 1990 Jul; 172(1):7-12. PubMed ID: 2141631
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of V beta 8+ T cells with lupus-like syndrome in MRL-lpr/lpr mice.
Fossati L; Merino R; Iwamoto M; Lemoine R; Izui S
Eur J Immunol; 1994 Jul; 24(7):1717-20. PubMed ID: 8026533
[TBL] [Abstract][Full Text] [Related]
19. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
Weston KM; Yeh ET; Sy MS
J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
[TBL] [Abstract][Full Text] [Related]
20. Reduction of mortality and lymphadenopathy in MRL-lpr/lpr mice treated with nonmitogenic anti-CD3 monoclonal antibody.
Henrickson M; Giannini EH; Hirsch R
Arthritis Rheum; 1994 Apr; 37(4):587-94. PubMed ID: 8147938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
